DIN 02405334 — SANDOZ ALMOTRIPTAN 12.5 MG
SANDOZ ALMOTRIPTAN is a tablet of Almotriptan marketed by SANDOZ CANADA INCORPORATED. The full Almotriptan monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02405334
- Brand name
- SANDOZ ALMOTRIPTAN
- Active ingredient
- Almotriptan
- Strength
- 12.5 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- SANDOZ CANADA INCORPORATED
- Health Canada status
- MARKETED
- Drug class
- 5-HT1 receptor agonist (triptan)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Almotriptan products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02424029 | ALMOTRIPTAN | 12.5 MG | TABLET | PRO DOC LIMITEE | MARKETED |
| 02466821 | ALMOTRIPTAN | 12.5 MG | TABLET | SANIS HEALTH INC | MARKETED |
| 02405806 | APO-ALMOTRIPTAN | 12.5 MG | TABLET | APOTEX INC | DORMANT |
| 02405792 | APO-ALMOTRIPTAN | 6.25 MG | TABLET | APOTEX INC | DORMANT |
| 02398443 | MYLAN-ALMOTRIPTAN | 12.5 MG | TABLET | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02398435 | MYLAN-ALMOTRIPTAN | 6.25 MG | TABLET | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02434849 | TEVA-ALMOTRIPTAN | 12.5 MG | TABLET | TEVA CANADA LIMITED | MARKETED |